Critical Care

  • COVID-19 coagulopathy
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/ccjm.87c.12001

    Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.

  • In Reply: COVID-19 coagulopathy
    Simon R. Mucha, MD, Siddharth Dugar, MD, Keith McCrae, MD, Douglas Joseph, DO, John Bartholomew, MD, Gretchen L. Sacha, PharmD, RPh, BCCCP and Michael Militello, PharmD, RPh, BCPS
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/cjm.87c.12002

    An attempt to balance the potential risks and benefits of intensified prophylaxis.

  • Dexamethasone or hydrocortisone in COVID-19?
    Chia Siang Kow, and Syed Shahzad Hasan,
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 715; DOI: https://doi.org/10.3949/ccjm.87c.12005

    Dexamethasone should be favored over hydrocortisone.

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

  • Neurologic complications of COVID-19
    Catherine E. Hassett, DO, Aron Gedansky, MD, Ibrahim Migdady, MD, Adarsh Bhimraj, MD, Ken Uchino, MD and Sung-Min Cho, DO
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 729-734; DOI: https://doi.org/10.3949/ccjm.87a.ccc058

    Human coronaviruses, including SARS-CoV-2, can be neurotropic.

  • Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19
    Chao-Ping Wu, MD, Fatima Adhi, MD and Kristin Highland, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 659-663; DOI: https://doi.org/10.3949/ccjm.87a.ccc015

    Consider the presentation and trajectory of illness.

  • Convalescent plasma for COVID-19: Promising, not proven
    Simon R. Mucha, MD and NurJehan Quraishy, MD
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 664-670; DOI: https://doi.org/10.3949/ccjm.87a.ccc056

    The evidence is suggestive but weak. Trials are ongoing.

  • COVID-19 and the kidney
    COVID-19 and the kidney
    Mohamed Hassanein, MD, Yeshwanter Radhakrishnan, MD, John Sedor, MD, Tushar Vachharajani, MD, Vidula T. Vachharajani, MD, Joshua Augustine, MD, Sevag Demirjian, MD and George Thomas, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 619-631; DOI: https://doi.org/10.3949/ccjm.87a.20072

    The kidney may be a target of SARS-CoV-2 infection.

  • Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention
    CME article
    Anita Rae Modi, MD and Christopher S. Kovacs, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 633-639; DOI: https://doi.org/10.3949/ccjm.87a.19117

    Better diagnosis, management, and prevention are needed.

  • SARS-CoV-2 and myocardial injury: Few answers, many questions
    SARS-CoV-2 and myocardial injury: Few answers, many questions
    Paul C. Cremer, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 521-525; DOI: https://doi.org/10.3949/ccjm.87a.ccc001

    What is the mechanism? Is this a distinct population? What are the treatment options?

Pages